User
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec B.V.
Sandifortdreef 17
2333 ZZ Leiden
The Netherlands
Phone: 0800 4020120
Fax: 0800 4020100
E-Mail: macs@miltenyibiotec.nl
Web: www.miltenyibiotec.com
For immediate technical support, use our live chat. Connect with us
Technical support - Clinical products
Phone:
Fax:
E-Mail: macs@miltenyibiotec.nl
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Researchers and opinion leaders have considered a number of potential solutions to the so-called antibody-related reproducibility “crisis”. One is to transition from traditional monoclonal antibodies to recombinant antibodies*.
So, what makes recombinant antibodies better and more effective than conventional hybridoma-derived antibodies?
We asked six experts from the flow cytometry and antibody community to share their opinion and experience with recombinant antibodies.
*Bradbury, A. and Plückthun, A. (2015) Reproducibility: Standardize antibodies used in research. Nature. 518: 27–29.
